高级搜索

累及野调强放疗联合同步化疗治疗局部晚期非小细胞肺癌的疗效观察

姚元虎, 章龙珍, 吴阳, 辛勇, 唐天友, 王建设, 张鑫君, 覃朝晖

姚元虎, 章龙珍, 吴阳, 辛勇, 唐天友, 王建设, 张鑫君, 覃朝晖. 累及野调强放疗联合同步化疗治疗局部晚期非小细胞肺癌的疗效观察[J]. 肿瘤防治研究, 2012, 39(03): 321-323. DOI: 10.3971/j.issn.1000-8578.2012.03.019
引用本文: 姚元虎, 章龙珍, 吴阳, 辛勇, 唐天友, 王建设, 张鑫君, 覃朝晖. 累及野调强放疗联合同步化疗治疗局部晚期非小细胞肺癌的疗效观察[J]. 肿瘤防治研究, 2012, 39(03): 321-323. DOI: 10.3971/j.issn.1000-8578.2012.03.019
Yao Yuanhu, Zhang Longzhen, Wu Yang, Xin Yong, Tang Tianyou, Wang Jianshe, Zhang Xinjun, Qin Zhaohui. Involved-field Irradiation Intensity Modulated Radiation Therapy with Concurrent Chemotherapy for Locally Advanced Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2012, 39(03): 321-323. DOI: 10.3971/j.issn.1000-8578.2012.03.019
Citation: Yao Yuanhu, Zhang Longzhen, Wu Yang, Xin Yong, Tang Tianyou, Wang Jianshe, Zhang Xinjun, Qin Zhaohui. Involved-field Irradiation Intensity Modulated Radiation Therapy with Concurrent Chemotherapy for Locally Advanced Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2012, 39(03): 321-323. DOI: 10.3971/j.issn.1000-8578.2012.03.019

累及野调强放疗联合同步化疗治疗局部晚期非小细胞肺癌的疗效观察

基金项目: 徐州市科技发展基金资助项目(XM08C076);江苏省高校自然科学研究项目资助课题(10KJD320004)
详细信息
    作者简介:

    姚元虎(1976-),男,硕士,副主任医师,主要从事肿瘤放射治疗的基础和临床研究

  • 中图分类号: R734.2

Involved-field Irradiation Intensity Modulated Radiation Therapy with Concurrent Chemotherapy for Locally Advanced Non-small Cell Lung Cancer

  • 摘要: 目的 比较累及野照射(IFI)和选择性淋巴结照射(ENI)调强放射治疗联合同步化疗治疗局部晚期非小细胞肺癌(LA-NSCLC)的不良反应和疗效。方法49例LA-NSCLC患者前瞻性随机分为IFI组和ENI组,同步化疗两周期,行根治性调强放射治疗。结果IFI组和ENI组≥2级放射性肺炎发生率分别为8.0%和37.5%(P=0.01);GTV平均剂量分别是(66.2±6.5)Gy和(61.3±6.3)Gy,(P=0.01);总有效率为92.0%和66.7%(P=0.03);预防照射区内淋巴结复发率为4.2%和4.0%,(P=0.49);1年局部失败率分别为8.0%和16.7%(P=0.62);1年生存率为72.0%和62.5%(P=0.48)。结论IFI同步放化疗治疗LA-NSCLC可降低正常组织并发症的概率,提高靶区照射剂量和肿瘤控制率,预防照射区内淋巴结复发率无增加,有望延长患者生存期。

     

    Abstract: Objective To compare toxicities and clinical outcomes of involved field irradiation (IFI)and with elective nodal irradiation (ENI)intensity modulated radiation therapy (IMRT)with concurrent chemotherapy for locally advanced non-small cell lung cancer (LA-NSCLC). Methods 49 patients with of LA-NSCLC were prospectively randomized into IFI group and ENI group,receiving 2 cycles of concurrent chemotherapy and radical IMRT. Results ≥grade 2 radiation pneumonitis developed in 8.0% of the patients in IFI group and 37.5% in ENI group (P=0.01).The mean prescription doses to grass tumor volumes with IFI and ENI were (66.2±6.5)Gy and (61.3±6.3)Gy (P=0.01).The responsive rates were 92.0% and 66.7% (P=0.03),and the elective nodal failure (ENF)rates were 4.2%and 4.0% (P=0.49),respectively.The 1-year local-failure rates were 8.0% and 16.7% (P=0.62),while the 1-year survival rates were72.0% and 62.5% (P=0.48),respectively. Conclusion IFI IMRT with concurrent chemotherapy for LA-NSCLC could reduce the probability of normal tissue complications and improve the target dose and tumor control rate without increasing incidence of elective nodal failure.It might further prolong patients' survival.

     

  • [1] Fidler MJ,Kim AW,Zusag T,et al.Treatment of locally advanced non-small cell lung cancer[J].Clin Adv Hematol Oncol,2009,7(7):455-464,479-480.
    [2] Sulman EP,Komaki R,Klopp AH,et al.Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer[J].Radiat Oncol,2009,4:5.
    [3] Yin WB,Yu ZH,Xu GZ,et al.Radiation oncology[M].4th edition.Beijing:Zhongguo Xie He Yi Ke Da Xue Chu Ban She,2008:1350-1374.[殷蔚伯,余子豪,徐国镇,等.肿瘤放射治疗学[M].4版.北京:中国协和医科大学出版社,2008:1350-1374.]
    [4] O’Rourke N,Macbeth F.Is concurrent chemoradiation the standard of care for locally advanced non-small cell lung cancer? A review of guidelines and evidence[J].Clin Oncol (R Coll Radiol),2010,22(5):347-355.
    [5] Wang SL,Liao ZX,Xiong W,et al.Analysis of clinical and dosimetric factors associated with treatment related pneumonitis(TRP)in patients with non-small-cell lung cancer(NSCLC)treated with concurrent chemotherapy and three-dimensional conformal radiotherapy(3D-CRT)[J].Int J Radiat Oncol Biol Phys,2006,66(5):1399-1407.
    [6] Sanuki-Fujimoto N,Sumi M,Ito Y,et al.Relation between elective nodal failure and irradiated volume in non-small-cell lung cancer (NSCLC)treated with radiotherapy using conventional fields and doses[J].Radiother Oncol,2009,91(3):433-437.
    [7] Fernandes AT,Shen J,Finlay J,et al.Elective nodal irradiation (ENI)vs.involved field radiotherapy (IFRT)for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes[J].Radiother Oncol,2010,95(2):178-184.
    [8] Yu JM,Sun XD,Li MH,et al.Involved-field three-dimensional conformal radiation treatment for stage Ⅲ non-small cell lung cancer[J].Zhonghua Zhong Liu Za Zhi,2006,28(7):526-529.[于金明,孙新东,李明焕,等.Ⅲ期非小细胞肺癌累及野照射的可行性研究[J].中华肿瘤杂志,2006,28(7):526-529.]
    [9] Yang KY,Can FJ,Wang JH,et al.Improved local coontrol without elective nodal in unresectable NSCLC patients treated by 3D-CRT[J].Zhonghua Fang She Yi Xue Yu Fang Hu Za Zhi,2007,27(5):480-482.[杨坤禹,曹凤军,王建化,等.选择性淋巴引流区照射对局部晚期非小细胞肺癌三维适形放疗疗效的影响[J].中华放射医学与防护杂志,2007,27(5):480-482.]
    [10] Yao YH,Zhang LZ,Wang X,et al.Involved-filed irradiation in three-dimensional conformal radiation therapy for elderly patients with advanced non-small cell lung cancer[J].Zhonghua Lao Nian Yi Xue Za Zhi,2009,28(12):976-978.[姚元虎,章龙珍,王侠,等.累及野三维适形放射治疗老年人非小细胞肺癌的疗效分析[J].中华老年医学杂志,2009,28(12):976-978.]
计量
  • 文章访问数:  3797
  • HTML全文浏览量:  31
  • PDF下载量:  713
  • 被引次数: 0
出版历程
  • 收稿日期:  2011-06-16
  • 修回日期:  2011-08-30
  • 刊出日期:  2012-03-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭